Open AccessTumor immune tissue response to a solitary fibrous tumor treated with pazopanib
Author(s) -
Kawano Toshiaki,
Hirano Takashi,
Fujinaga Maki,
Kadowaki Yoshinori,
Matsunaga Takayuki,
Tateyama Kaori,
Kizu Yumi,
Suzuki Masashi
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4056
Subject(s) - pazopanib , solitary fibrous tumor , medicine , immune system , pathology , vegf receptors , oncology , cancer research , immunology , renal cell carcinoma , biology , stem cell , cd34 , sunitinib , genetics
In our case, tumor tissues were collected thrice during the course of treatment for immunohistological evaluation. The tumor was consistently positive for VEGF, suggesting that pazopanib was effective in the treatment of solitary fibrous tumor.